Participated · Series D · Nov 2025

Los Angeles–based Metropolis has built an AI and computer-vision platform that recognizes people and vehicles in real time, enabling checkout-free payments and personalized experiences across parking, retail, hospitality, mobility and fueling locations. The company processes more than $5 billion in annual transactions for 50 million customers and has nearly 20 million registered Members, with more than one million new Members joining each month. Its network spans over 4,200 locations in 40 countries and, following the 2024 take-private of SP+ and the 2025 purchase of biometrics firm Oosto, Metropolis is now the largest parking network in the United States. The platform underpins what the company calls the “Recognition Economy,” replacing friction with presence-based recognition to streamline real-world commerce. Current expansion efforts target quick-service restaurants, refueling stations, hotels, stadiums and other high-traffic venues. Management positions the company as one of the fastest-growing tech firms in the U.S., supported by deep partnerships with retailers, asset owners and real-estate operators. The newly raised capital will fund further product development, geographic expansion and additional vertical integrations.

Participated · Series C · Feb 2022

Alchemy provides a developer platform that removes the complexity and costs of building blockchain and web3 applications, charging customers for compute units based on usage. The company says it has powered $105 billion of annualized on-chain transactions and has seen dramatic platform growth. Alchemy launched its offering in August 2020 and positions itself as the de facto platform for developers and mainstream blockchain applications. It is profitable but declines to disclose hard revenue figures; the team reports over 3x growth in the number of teams building since its October raise and nearly 50% user‑base growth since the latest round. Alchemy has expanded its ecosystem activities by launching Web3 University and creating Alchemy Ventures, which has allocated $10 million to invest in nascent web3 businesses. The company plans to use new capital to hire aggressively and expects headcount to reach about 200 by year‑end. Alchemy offers a developer platform intended to simplify building on blockchains, positioning itself as the "AWS for blockchain" and launching its product in August 2020. The platform powers transactions across financial institutions, exchanges, major DeFi projects and NFT marketplaces such as OpenSea, MakersPlace, Nifty Gateway, SuperRare and CryptoPunks, and counts customers including Dapper Labs, Axie Infinity, Adobe, PwC and UNICEF. Alchemy now handles over $45 billion in transaction volume (up from $30 billion in April) and has expanded support beyond Ethereum to Polygon, Arbitrum, Optimism and Flow. The company reports it is "very profitable" and that revenue grew 15x since its last raise in April; it also still holds the $80 million it raised in its Series B. Alchemy remains a lean team of 27 employees, based in San Francisco with an office in New York and remote staff globally. The company plans to use the new capital primarily to invest in building a community around blockchain and to continue improving tooling for developers. Alchemy builds a SaaS developer platform that removes the complexity and costs of blockchain infrastructure for developers. The platform powers transactions across nearly every blockchain vertical and is the underlying technology for most major NFT platforms, including OpenSea, Nifty Gateway, SuperRare and CryptoPunks. The company says it has powered more than $30 billion in transactions for tens of millions of users and reported revenue growth of 600% in 2020. Alchemy launched in 2017 and has kept a relatively small team (growing recently from 14 to 22 employees) while planning to 5x headcount this year. It plans to use new capital to support additional blockchains, fuel global expansion, and open new offices, including a planned New York office. Alchemy and its backers position the company as the “AWS for blockchain,” aiming to be the primary developer platform for mainstream blockchain adoption. Alchemy replaces the nodes businesses use to read and write blockchains with a faster, more scalable decentralized architecture and bundles developer tools such as analytics, monitoring, alerting, logging and debugging. The two-year-old startup already powers infrastructure for hundreds of businesses, serving over one million customers in 200 countries per week, with clients including Augur, 0x, CryptoKitties, Kyber and the Opera browser. The company charges for tools and service packages that the founders say start in the tens of thousands of dollars and reports meaningful revenue from those sales. Alchemy says its platform resolves reliability issues, speeds applications (customers reported multi‑fold improvements) and returns engineering time to product development. The founders emphasize close customer support and rapid iteration—founders remain directly accessible to customers and the team has just hired its first salesperson to pursue larger corporate deals. Alchemy has turned away acquisition interest and is focused on building more tools to accelerate blockchain developer adoption and to win a breakout mainstream use case.

Participated · Series D · Jul 2021

NotCo uses a proprietary artificial‑intelligence platform called Giuseppe to recreate the taste, texture, functionality and smell of animal‑based foods using only plant ingredients; the technology is covered by 12 U.S. patents. The company sells branded products such as NotMilk™, NotBurger™ and NotChicken™ through retail and foodservice channels and reports placement in over 10,000 stores including Costco, Whole Foods, Amazon and others. NotCo has pursued B2B expansion, launching a new B2B unit and platform to license Giuseppe to other CPG brands, ingredient suppliers and technology partners. It has already demonstrated licensing via a joint venture with Kraft Heinz, The Kraft Heinz Not Company, to reimagine Kraft products. The company touts dramatically faster R&D timelines using its AI — cutting development from years to months — as a core advantage for scaling plant‑based innovation. Financially, NotCo recently completed a $70M Series D1 that reaffirmed a $1.5B valuation at the same share price as its July 2021 Series D. NotCo builds plant-based consumer products — including NotMilk, NotBurger/NotMeat, NoticeCream and NotMayo — sold in the U.S., Brazil, Argentina, Chile and Colombia and carried in retailers like Whole Foods, Sprouts and Wegmans. Its proprietary AI, Giuseppe, analyzes thousands of plant ingredients to recreate animal-protein attributes and accelerate product development. The company has raised more than $350 million to date and completed a $235 million Series D at a $1.5 billion valuation. Sales have grown roughly threefold annually over the past four years, and the company currently employs about 100 people with plans to double headcount in two years. NotCo plans to expand into Mexico and Canada, increase U.S. and Chile market share, and pursue Asia and Europe expansion within the next year while adding new products such as chicken/white meats and seafood and investing in R&D and additional patents. NotCo uses a patented artificial intelligence platform called Giuseppe to identify plant ingredients that replicate the taste, texture, and functionality of animal-based foods. The company has launched products across multiple categories — NotMilk™, NotBurger™, NotIceCream™ and NotMayo™ — and competes in five countries within four product categories. NotCo recently rolled out NotMilk nationwide at Whole Foods in the U.S. and confirmed distribution in more than 3,000 stores in the first half of 2021. The company operates in the U.S., Brazil, Argentina, Chile and Colombia and says it is the largest and fastest-growing food tech company in Latin America. Management plans to use new capital to accelerate U.S. expansion, deepen entry into NYC foodservice, and fund new category innovation in Latin America. NotCo has raised more than $130 million to date and said the latest investment was made at a higher valuation than its prior round, with a goal of reaching a $1 billion valuation by the end of 2021. NotCo is built on proprietary artificial intelligence that matches animal protein to ideal plant-based ingredients to recreate the taste and behavior of dairy, eggs and meat. The company has launched NotMilk, NotBurger, NotIceCream and NotMayo across Brazil, Argentina and Chile and says it has become the largest and fastest-growing food-tech company in Latin America in less than three years. NotCo has commercial partnerships with Burger King and Papa John’s in Chile and will evaluate additional food-service and retail partners as it expands. The company plans to scale operations internationally with an entry into the United States and will base co-founders Matias Muchnick (CEO) and Karim Pichara (CTO) in the U.S. to accelerate expansion. NotCo has added senior hires for global marketing, business development, R&D and operations to build its leadership team. The firm cites accelerating market demand for plant-based products—U.S. grocery sales of direct animal-replacement plant-based foods grew 29% to $5 billion over two years—as supporting its expansion plans. NotCo is a Chilean food-technology company that develops plant-based replacements for mayonnaise, milk, ice cream, meat and other animal-based products. The company combines machine AI and human taste expertise to design recipes, leveraging Giuseppe, a machine AI platform that analyzes molecular structures to create unique plant-based combinations. NotCo was founded in 2015 by Matias Muchnick, Pablo Zamora and Karim Pichara. The business focuses on alternative, plant-based consumer packaged foods across multiple categories. The $30M raised will be used for technological advancement, new product development and expansion into new markets, including Mexico and the US later in the year. Existing investor relationships include Kaszek Ventures and IndieBio.

Participated · Equity · Jul 2019

The Boring Company develops and builds tunnel-based transportation systems that combine underground tunnels with surface routes and vehicle transit. It operates a system in Las Vegas and has proposed or planned networks in Nashville, Baltimore, Chicago, Los Angeles and a multi-phase project in Dubai with publicly reported cost and timeline estimates. The firm was spun out of SpaceX in 2018 and has been pursuing large-scale expansion funded by recent private-market interest. Financially, reporting highlights a proposed $4 billion capital raise that would value the company at about $20 billion, a substantial increase from its $5.7 billion 2022 valuation. The company faces operational and regulatory headwinds, including reports of serious worker injuries and nearly 800 environmental violations in Nevada. Government discussions have also positioned the company as a potential contractor on major infrastructure projects, including work related to an Amtrak tunnel project.

Participated · Seed · Apr 2019

Vital builds AI- and NLP-powered, consumer-grade software to help hospitals communicate with and engage patients during emergency department and inpatient stays. Its products include ERAdvisor for the ED and CareAdvisor for inpatient settings, accessible via patients' mobile phones with no download or password required. The cloud-based, HIPAA-compliant platform sits on top of existing EHRs (Epic, Cerner, Meditech), automates communications, delivers personalized patient content, and offers features such as lab results and experience management. Vital reports partnerships with over 100 hospitals and 31 health systems, added more than 40 new hospital clients over the past year including Allina Health, CommonSpirit Health and Emory Healthcare, and is on pace to impact over one million patient lives and support 100,000 clinical tasks in 2023. The company has raised over $40 million to date and says its platform generates millions in revenue for health systems while reducing clinician burden and improving staff satisfaction. Founded by Aaron Patzer and Dr. Justin Schrager and headquartered in Claymont, Delaware, Vital plans to expand its team and launch new features focused on clinical decision support, care coordination and patient experience. Vital is an Atlanta-based, HIPAA-compliant, cloud-based software company launched in 2019 that adds AI and user-experience layers to existing electronic health record systems for hospital emergency departments. Its ERAdvisor mobile web application gives patients and caregivers real-time updates on wait times, lab statuses, and next steps, while the platform predicts wait times and highlights workflow bottlenecks across the ED. The software is designed to improve patient experience, care coordination, and prioritization of patients during ED visits and into inpatient stays. Vital is used in more than 80 hospitals across 15 healthcare systems, including CommonSpirit Health and Emory Healthcare. The company raised $15M in a Series A and plans to use the funds to expand its team and broaden and deepen the impact of its technology across U.S. hospitals. Vital provides a software integration layer on top of existing electronic health records to simplify emergency department workflows and reduce paperwork for clinicians. It uses a two-sided application where admitting staff begin a record and patients receive a text survey to supply height, weight, recent surgeries, medications, allergies, a photo, and an insurance card image. That patient-provided data feeds a tracking board used by doctors and nurses; triage nurses then confirm details and take vital signs. An algorithm analyzes the collected information to predict a course of treatment and help prioritize care. The company says the product cuts wait times in half, reduces provider burnout, and can save hospitals millions; it sells to emergency rooms with a starting sticker price of $10,000 per month. Founder Aaron Patzer invested $1 million and two years of peer-reviewed academic study and R&D into the product; co-founder Justin Schrager is an emergency medicine physician at Emory University Hospital.